Stanford-backed iRhythm raises $16m series D round led by Norwest Venture Partners.
iRhythm, a Stanford University spin out medical device firm, has raised $16m in a series D round led by Norwest Venture Partners (NVP). The US-based startup, which was spun out of Stanford’s biodesign programme, also attracted return investment in the round from existing backers, including New Leaf Ventures, Synergy Life Science Partners, and Kaiser Permanente…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
